CEO

• Oct 2018 - Present

Humedics, based in Berlin, focuses on rapid and precise liver function measurement using LiMAx, its innovative breath analysis technology. This easy-to-use bedside test provides doctors with accurate information to support decision making in tailoring the medical treatment to the individual level of each patient and to improve patient outcomes.LiMAx has already been used on thousands of patients and the company is currently expanding its operation globally.

CFO

• Aug 2020 - Present

Paladino Insurtech has a technology platform which enables its customers to bring new insurance solutions to the market faster and more efficiently

Owner

• Nov 2010 - Present

Project based work on a mandate basis for various clients mainly in healthcare and related sectors. Currently engaged as part-time CEO and CFO for two companies, one in Switzerland and one in Germany. Also involved in the founding of a start-up in electron holography. Written many business / strategic development plans; liquidated several companies.

CFO

• Mar 2018 - Aug 2020

Part-time CFO for this ETH spin-off, which is developing the next generation of skin-contact electrodes.

Group Chief Financial Officer

• Mar 2014 - Jul 2018

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch was taken over by BioTelemetry, Inc., a Nasdaq quoted company carrying out similar business, in July 2017. Appointed CFO on April 1st, 2016 having previously been Chief of Staff. Responsible, amongst other things, for all financial matters and investor relations, which included writing a prospectus for a capital increase in 2016 and supervising the entire due diligence process surrounding the sale of the company (multiple bids).

Board Member / CFO

• Feb 2010 - Apr 2013

Responsible for all areas of the Swiss business except Operations. Business successfully sold in late 2012 to a UK stock exchange quoted company. Oversaw the entire due diligence process and carried out many company transactions whilst at the company, e.g. transfer of a Swiss branch to a Swiss company, spin-off of a subsidiary to existing shareholders in the UK quoted parent, integrated an acquisition.

CFO (Part-time)

• Jun 2006 - Nov 2011

Responsible for finance, documentation and contracts as well as all contact with the authorities (regulated fund management company).

Managing Director / CFO

• Aug 2004 - Jun 2008

IMI was developing artificial vision for patients with Retinal Pigmentosa or Macular Degeneration. Responsible for all aspects of this VC funded start-up except technical development. EUR 15 million financing successfully organised, negotiated and closed.

Partner / Chief Investment Officer / Board Member

• Sep 2000 - May 2004

Kaelin Management AG advised and managed CHF 500m for two stock exchange quoted investment companies, which focused mainly on new business opportunities in IT and sustainability. Responsible for finding, appraising and scrutinising potential investment projects and, following investment, monitoring the performance, which typically included board membership.

Director

• Jun 1995 - Aug 2000

Member of Senior Management

• Mar 1994 - May 1995

Member of Senior Management

• Jun 1990 - Feb 1994

Assistant Manager

• Jan 1989 - Jun 1990

CFO

• Feb 1986 - Dec 1988

Senior Auditor

• Jun 1983 - Jan 1986

Responsible for internal audits in London and New York.

Senior Auditor

• Jun 1982 - Jun 1983

Team member for internal audits throughout Europe.

Audit Senior

• Sep 1978 - May 1982

Responsible for external audits.